http://www.fpnotebook.com/
Gonadotropin-releasing Hormone AgonistAka: GnRH agonist, Nafarelin Acetate, Synarel
- Indication
- Endometriosis
- Pathophysiology
- Potentiates Gonadotropin-releasing hormone (GnRH)
- Results in hypoestrogenism or pseudo-Menopause
- Does not cause the same androgenic effects as Danazol
- Dosing: Nafarelin acetate (Synarel)
- Synarel 200-400 micro-g intranasally bid
- Efficacy
- Effective at regression of lesions and relief of pain
- No proven effect on fertility
- Adverse effects
- Menopausal symptoms
- Hot Flashes
- Insomnia
- Emotional changes
- Bone density loss with prolonged use
|
|---|
| Concepts | Amino Acid, Peptide, or Protein (T116)
, Pharmacologic Substance (T121)
|
| English | Synarel |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree